MetLife Investment Management, LLC - STEMLINE THERAPEUTICS INC ownership

STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 83 filers reported holding STEMLINE THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 6.94 and the average weighting 0.2%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of STEMLINE THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$89,400
-54.5%
18,4710.0%0.00%
-50.0%
Q4 2019$196,347
+2.1%
18,4710.0%0.00%0.0%
Q3 2019$192,283
-32.0%
18,4710.0%0.00%
-33.3%
Q2 2019$282,976
+19.2%
18,4710.0%0.00%0.0%
Q1 2019$237,352
+109.1%
18,471
+54.6%
0.00%
+200.0%
Q4 2018$113,497
-42.8%
11,9470.0%0.00%
-50.0%
Q3 2018$198,320
+3.3%
11,9470.0%0.00%0.0%
Q2 2018$192,000
+4.9%
11,9470.0%0.00%0.0%
Q1 2018$183,000
-1.6%
11,9470.0%0.00%0.0%
Q4 2017$186,00011,9470.00%
Other shareholders

There were no reported owners of STEMLINE THERAPEUTICS INC in Q1 2018.

NameSharesValueWeighting ↓
View complete list of STEMLINE THERAPEUTICS INC shareholders